Research & Development

caoporn免费超碰在线超碰av精在线视频超碰新免费视频公开估值分化无碍科创板打新热情 机构限规模散户全出动


  中間絕對不能有任何的偏差,即便是長平想要在羊肉吃完之前煮點豆腐吃也絲毫不給面子。   “我大哥贏了!”霍光從大氅里費力的探出頭問雲瑯。caoporn免费超碰在线   自從生下來,他就沒有得到過太好的東西。超碰av精在线视频   眼看著霍去病的白蠟桿子點在張氏的眼前,這一場龍爭虎斗總算是結束了。   雲瑯笑道︰“霍公多慮了,只要去病在,霍氏當無憂患。”超碰新免费视频公开   “雲瑯拿出了一千斤黃金,雲氏所有的家底來補償你!”平叟還是將竹簡遞給了卓姬。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo